The French Life Sciences Web Portal
This is a free web portal for the life sciences in France and Monaco... » read more
- Cerenis Therapeutics Reports 2016 Annual Results (2017-02-17)
Cerenis Therapeutics (FR0012616852- CEREN), an international biopharmaceutical company dedicated to the discovery and development of innovative HDL therapies (“good cholesterol”) for treating cardiovascular and metabolic diseases, today announces its full-year 2016...
- Sartorius Enters Corporate Partnership Program with EMBL (2017-02-17)
> Sartorius and EMBL join forces to offer advanced training and science education > Sartorius is now a member of the group of corporate EMBL partners aiming to connect industry to academia Sartorius, a leading international laboratory and pharmaceutical equipm...
- Inventiva Raises €48m in IPO at Euronext Paris (2017-02-15)
Euronext today welcomed Inventiva, a biopharmaceutical company specialised in the development of new therapies, particularly for fibrotic diseases, to Compartment C of its regulated market in Paris. Inventiva was founded in 2012 and delivers innovative therapie...
- Servier and GAIA Extend Their Partnership in Depression (2017-02-14)
An innovative complementary way to treat depression adapted to patients’ needs Servier, an independent international pharmaceutical company, and GAIA, a global pioneer in digital therapy, announced today that they have signed a partnership to extend the market...
- Premaitha: Partnership with European Diagnostics Group (2017-02-13)
Premaitha Health PLC (AIM: NIPT), developer of a leading CE-marked non-invasive prenatal screening system, announces a partnership with a major international diagnostics services group to implement the IONA® test in at least two laboratories. Premaitha, through ...
- Ipsen to Acquire Consumer Healthcare Products from Sanofi (2017-02-13)
> Transaction leverages Primary Care infrastructure and accelerates conversion to OTx1 business model > Ipsen to pay €83 million cash upon closing for the products Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has entered into a definitive agree...
- Lysogene Lists on Euronext, IPO Raises €22.6m (2017-02-08)
Euronext today welcomed Lysogene, a company specialized in gene therapy targeting two rare diseases of the central nervous system, to Compartment C of its regulated market in Paris. Lysogene is the first biotechnology company to join the Paris market in 2017. A ...
- Global Bioenergies: First Production of Fully Renewable ETBE (2017-02-07)
In a historic first, Global Bioenergies today announces the production of ETBE purely from renewable resources. The breakthrough heralds a new opportunity for increasing the proportion of biofuels in gasoline. Current standards limit the inclusion of traditional...
- Lipotype Is Partner in New IMI Project BEAt-DKD (2017-02-06)
BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Ju...
- Euronext »Biotech Barometer« Highlights Listed Biotech Firms (2017-02-02)
> The “Biotech Barometer" highlights listed biotech companies > A quarterly review designed to identify market trends > Barometer reveals renewed interest in biotech stocks despite cautious market segment in Q4 2016 Euronext today published its first “Bi...
Life-Sciences-France.com is your doorway to the French life sciences!
[LSF] provides free, up-to-date and structured access to
in France and Monaco.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!Start here with the latest News!
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)